ACCESS CHINA has been held every quarter since 2020 and serves as a China cross-border corporate access platform. In its 2 years of bringing together international and China Biotech BDs and CEOs, ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
We cordially invite you to join our “ACCESS CHINA Biotech Forum Spring Showcase 2022” to be held online from June 21st – 24th, 2022. ACCESS CHINA forum expects to have over 1000 participants from China pharma and Biotech companies.
We welcome the following global pharma and biotech to showcase:
- Looking for out-/in-licensing opportunities in China
- With clinical-stage innovative drug assets
Who are the attendees?
- 50% are Chinese pharma/biotechs looking for in-licensing opportunities to enrich pipeline
- 25% are Pharma/biotech outside China looking for in-licensing opportunities to enrich pipeline in China and other regions
- 15% are VCs and PEs looking for pharma/biotech investment opportunities
previous participants:
BioToChina.org 